Literature DB >> 24413543

Possible link between Toxoplasma gondii and the anosmia associated with neurodegenerative diseases.

Joseph Prandota1.   

Abstract

Toxoplasma gondii is an intracellular protozoan infecting 30% to 50% of global human population. Recently, it was suggested that chronic latent neuroinflammation caused by the parasite may be responsible for the development of several neurodegenerative diseases manifesting with the loss of smell. Studies in animals inoculated with the parasite revealed cysts in various regions of the brain, including olfactory bulb. Development of behavioral changes was paralleled by the preferential persistence of cysts in defined anatomic structures of the brain, depending on the host, strain of the parasite, its virulence, and route of inoculation. Olfactory dysfunction reported in Alzheimer's disease, multiple sclerosis, and schizophrenia was frequently associated with the significantly increased serum anti-T gondii immunoglobulin G antibody levels. Damage of the olfactory system may be also at least in part responsible for the development of depression because T gondii infection worsened mood in such patients, and the olfactory bulbectomized rat serves as a model of depression.

Entities:  

Keywords:  anosmia; autoimmune diseases; cerebral toxoplasmosis; depression; impaired smell; neurodegeneration; olfaction

Mesh:

Year:  2014        PMID: 24413543     DOI: 10.1177/1533317513517049

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  13 in total

1.  Reexamining Chronic Toxoplasma gondii Infection: Surprising Activity for a "Dormant" Parasite.

Authors:  Anthony P Sinai; Elizabeth A Watts; Animesh Dhara; Robert D Murphy; Matthew S Gentry; Abhijit Patwardhan
Journal:  Curr Clin Microbiol Rep       Date:  2016-10-04

Review 2.  Interactions between the microbiota, immune and nervous systems in health and disease.

Authors:  Thomas C Fung; Christine A Olson; Elaine Y Hsiao
Journal:  Nat Neurosci       Date:  2017-01-16       Impact factor: 24.884

Review 3.  Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions.

Authors:  Aleah Holmes; Carson Finger; Diego Morales-Scheihing; Juneyoung Lee; Louise D McCullough
Journal:  Transl Res       Date:  2020-08-02       Impact factor: 7.012

4.  Infection and characterization of Toxoplasma gondii in human induced neurons from patients with brain disorders and healthy controls.

Authors:  Eleonora Passeri; Lorraine Jones-Brando; Claudia Bordón; Srona Sengupta; Ashley M Wilson; Amedeo Primerano; Judith L Rapoport; Koko Ishizuka; Shin-ichi Kano; Robert H Yolken; Akira Sawa
Journal:  Microbes Infect       Date:  2015-10-09       Impact factor: 2.700

5.  Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.

Authors:  J A Portes; W De Souza
Journal:  Parasitol Res       Date:  2019-11-14       Impact factor: 2.289

6.  3-D imaging and analysis of neurons infected in vivo with Toxoplasma gondii.

Authors:  Anita A Koshy; Carla M Cabral
Journal:  J Vis Exp       Date:  2014-12-09       Impact factor: 1.355

7.  Pathogenic microbes, the microbiome, and Alzheimer's disease (AD).

Authors:  James M Hill; Christian Clement; Aileen I Pogue; Surjyadipta Bhattacharjee; Yuhai Zhao; Walter J Lukiw
Journal:  Front Aging Neurosci       Date:  2014-06-16       Impact factor: 5.750

8.  Midichlorians--the biomeme hypothesis: is there a microbial component to religious rituals?

Authors:  Alexander Y Panchin; Alexander I Tuzhikov; Yuri V Panchin
Journal:  Biol Direct       Date:  2014-07-02       Impact factor: 4.540

9.  Biotic/Abiotic Stress-Driven Alzheimer's Disease.

Authors:  Chang-Qing Li; Qing Zheng; Qi Wang; Qing-Ping Zeng
Journal:  Front Cell Neurosci       Date:  2016-11-23       Impact factor: 5.505

10.  Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer.

Authors:  Huân M Ngô; Ying Zhou; Hernan Lorenzi; Kai Wang; Taek-Kyun Kim; Yong Zhou; Kamal El Bissati; Ernest Mui; Laura Fraczek; Seesandra V Rajagopala; Craig W Roberts; Fiona L Henriquez; Alexandre Montpetit; Jenefer M Blackwell; Sarra E Jamieson; Kelsey Wheeler; Ian J Begeman; Carlos Naranjo-Galvis; Ney Alliey-Rodriguez; Roderick G Davis; Liliana Soroceanu; Charles Cobbs; Dennis A Steindler; Kenneth Boyer; A Gwendolyn Noble; Charles N Swisher; Peter T Heydemann; Peter Rabiah; Shawn Withers; Patricia Soteropoulos; Leroy Hood; Rima McLeod
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.